Scognamiglio Francesca, Travan Andrea, Borgogna Massimiliano, Donati Ivan, Marsich Eleonora
Department of Life Sciences, University of Trieste, Trieste, Italy.
Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
J Biomed Mater Res A. 2020 May;108(7):1534-1545. doi: 10.1002/jbm.a.36924. Epub 2020 Mar 27.
Biodegradable membranes for cartilage applications were manufactured starting from polymeric networks of a lactose-modified chitosan (CTL), previously proposed for chondrocytes stimulation. This implantable biomaterial was conceived as a reservoir of a bioactive polymer that could promote the activity of chondrocytes and the healing of cartilage defects. Freeze-drying of reticulated hydrogels enabled to obtain pliable membranes with a homogeneous polymeric texture, as pointed out by scanning electron microscopy analyses. Swelling tests and dimensional evaluations showed that the material is able to absorb physiological fluids and expand gradually upon rehydration. This feature was evaluated on a simulated cartilage defect on pig's humerus (ex vivo), which revealed the capability of the membranes to progressively fit the tissue voids on the damaged cartilage. The rheological properties of the rehydrated membranes pointed out their peculiar strain-stiffening behavior, which represents a promising feature for the regeneration of tissues subjected to variable mechanical loads and deformations. Biological in vitro studies demonstrated the biocompatibility of the membranes in contact with primary chondrocytes and osteoblasts. Taken together, these results represent a starting point for the development of a novel generation of implantable biomaterials for cartilage treatment based on CTL.
用于软骨应用的可生物降解膜是从乳糖修饰壳聚糖(CTL)的聚合物网络开始制造的,此前已提出该聚合物用于刺激软骨细胞。这种可植入生物材料被设想为一种生物活性聚合物的储存库,可促进软骨细胞的活性和软骨缺损的愈合。扫描电子显微镜分析表明,网状水凝胶的冷冻干燥能够获得具有均匀聚合物质地的柔韧膜。溶胀试验和尺寸评估表明,该材料能够吸收生理流体并在重新水化时逐渐膨胀。在猪肱骨的模拟软骨缺损(体外)上评估了这一特性,结果表明该膜能够逐渐填充受损软骨上的组织空隙。重新水化膜的流变学特性表明其具有独特的应变硬化行为,这对于承受可变机械载荷和变形的组织再生来说是一个有前景的特性。体外生物学研究证明了该膜与原代软骨细胞和成骨细胞接触时的生物相容性。综上所述,这些结果是基于CTL开发新一代用于软骨治疗的可植入生物材料的起点。